MENU
+Compare
EOLS
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$6.73
Change
+$0.33 (+5.16%)
Capitalization
435.33M

EOLS Evolus Forecast, Technical & Fundamental Analysis

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market... Show more

EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EOLS with price predictions
Aug 15, 2025

EOLS sees MACD Histogram crosses below signal line

EOLS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 30, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EOLS as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

EOLS moved below its 50-day moving average on July 25, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EOLS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EOLS's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where EOLS advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

EOLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EOLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: EOLS's P/B Ratio (116.279) is slightly higher than the industry average of (16.499). P/E Ratio (0.000) is within average values for comparable stocks, (72.127). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.761). EOLS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (1.542) is also within normal values, averaging (40.137).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EOLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EOLS is expected to report earnings to fall 80.41% to -5 cents per share on November 11

Evolus EOLS Stock Earnings Reports
Q3'25
Est.
$-0.05
Q2'25
Missed
by $0.17
Q1'25
Missed
by $0.21
Q4'24
Missed
by $0.13
Q3'24
Missed
by $0.18
The last earnings report on August 05 showed earnings per share of -27 cents, missing the estimate of -10 cents. With 1.07M shares outstanding, the current market capitalization sits at 435.33M.
A.I. Advisor
published General Information

General Information

a manufacturer of neurotoxins

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
520 Newport Center Drive
Phone
+1 949 284-4555
Employees
273
Web
https://www.evolus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCSDX17.59N/A
N/A
Fidelity Advisor Strategic Div & Inc C
TOCQX51.68-0.17
-0.33%
Tocqueville
PESPX28.88-0.16
-0.55%
BNY Mellon MidCap Index Inv
TMIRX10.83-0.06
-0.55%
Transamerica Mid Cap Growth R
RSMVX10.73-0.07
-0.65%
William Blair Small-Mid Cap Value R6

EOLS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with PRGO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+5.16%
PRGO - EOLS
43%
Loosely correlated
-1.43%
AMRX - EOLS
33%
Poorly correlated
+0.64%
LNTH - EOLS
33%
Poorly correlated
-0.53%
ALKS - EOLS
30%
Poorly correlated
+2.80%
AKBA - EOLS
28%
Poorly correlated
-1.22%
More

Groups containing EOLS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+5.16%
Pharmaceuticals: Generic
industry (228 stocks)
7%
Poorly correlated
-1.77%